计算溶液所需的质量、体积或浓度。
| 活性类型 | 活性值-log(M) | 作用机制 | 期刊 | 参考文献(PubMed IDs) |
|---|
| 货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
|---|---|---|---|---|
| G414233-2mg |
2mg |
现货 ![]() |
| |
| G414233-5mg |
5mg |
现货 ![]() |
| |
| G414233-10mg |
10mg |
现货 ![]() |
| |
| G414233-25mg |
25mg |
现货 ![]() |
| |
| G414233-50mg |
50mg |
现货 ![]() |
| |
| G414233-100mg |
100mg |
现货 ![]() |
|
| 规格或纯度 | Moligand™, ≥98% |
|---|---|
| 英文名称 | GSK8612 |
| 生化机理 | GSK8612 是一种高效的 TBK1(坦克结合激酶-1)选择性抑制剂,pKd 为 8.0。GSK8612 与 TBK1 的亲和力在 10 倍以内,没有发现 GSK8612 的非靶点。 |
| 储存温度 | 避光,-20°C储存 |
| 运输条件 | 超低温冰袋运输 |
| 作用类型 | 抑制剂 |
| 作用机制 | 核因子卡巴 B 激酶亚基 Epsilon 抑制剂;TANK 结合激酶 1 抑制剂 |
| 产品介绍 |
GSK8612是高效选择性TBK1抑制剂,pKd为8。 Information GSK8612 GSK8612 is a highly potent and selective inhibitor for TBK1 (Tank-binding Kinase-1) with pKd of 8.0. Within 10-fold affinity with respect to TBK1, no off-targets of GSK8612 could be identified. Targets TBK1 6.8(pIC50) In vitro In cellular assays, this small molecule inhibits toll-like receptor (TLR)3-induced interferon regulatory factor (IRF)3 phosphorylation in Ramos cells and type I interferon (IFN) secretion in primary human mononuclear cells. In THP1 cells, GSK8612 is able to inhibit secretion of interferon beta (IFNβ) in response to dsDNA and cGAMP, the natural ligand for STING. GSK8612 has lower affinity for phosphorylated TBK1. GSK8612 inhibits recombinant TBK1 with an average pIC50 of 6.8 in a biochemical functional assay. The actual selectivity of GSK8612 for TBK1 in the cells will depend on the activation state of TBK1. In vivo GSK8612 is highly protein bound in mouse, rat and human blood. |
| ALogP | 3.447 |
|---|---|
| HBD Count | 3 |
| Rotatable Bond | 8 |
| 作用机制 | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | 参考文献 |
|---|
| PubChem SID | 504773501 |
|---|---|
| 分子类型 | 未知 |
| IUPAC Name | 4-[[[5-bromo-2-[[3-methyl-1-(2,2,2-trifluoroethyl)pyrazol-4-yl]amino]pyrimidin-4-yl]amino]methyl]benzenesulfonamide |
| INCHI | InChI=1S/C17H17BrF3N7O2S/c1-10-14(8-28(27-10)9-17(19,20)21)25-16-24-7-13(18)15(26-16)23-6-11-2-4-12(5-3-11)31(22,29)30/h2-5,7-8H,6,9H2,1H3,(H2,22,29,30)(H2,23,24,25,26) |
| InChi Key | FFPHMUIGESPOTK-UHFFFAOYSA-N |
| Canonical SMILES | CC1=NN(C=C1NC2=NC=C(C(=N2)NCC3=CC=C(C=C3)S(=O)(=O)N)Br)CC(F)(F)F |
| Isomeric SMILES | CC1=NN(C=C1NC2=NC=C(C(=N2)NCC3=CC=C(C=C3)S(=O)(=O)N)Br)CC(F)(F)F |
| PubChem CID | 137553174 |
| 分子量 | 520.33 |
| 溶解性 | Solubility (25°C) In vitro DMSO: 100 mg/mL (192.18 mM); Ethanol: 6 mg/mL (11.53 mM); Water: Insoluble; |
|---|---|
| 敏感性 | 对光线敏感 |
| DMSO(mg / mL) Max Solubility | 100 |
| DMSO(mM) Max Solubility | 192.185728287817 |
| Water(mg / mL) Max Solubility | <1 |
| 分子量 | 520.299 g/mol |
| XLogP3 | 2.900 |
| 氢键供体数Hydrogen Bond Donor Count | 3 |
| 氢键受体数Hydrogen Bond Acceptor Count | 11 |
| 可旋转键计数Rotatable Bond Count | 7 |
| 精确质量Exact Mass | 519.03 Da |
| 单同位素质量Monoisotopic Mass | 519.03 Da |
| 拓扑极表面积Topological Polar Surface Area | 136.000 Ų |
| 重原子数Heavy Atom Count | 31 |
| 形式电荷Formal Charge | 0 |
| 复杂度Complexity | 688.000 |
| 同位素原子数Isotope Atom Count | 0 |
| 定义的原子立体中心计数Defined Atom Stereocenter Count | 0 |
| 未定义的原子立体中心计数Undefined Atom Stereocenter Count | 0 |
| 定义的键立体中心计数Defined Bond Stereocenter Count | 0 |
| 未定义的键立体中心计数Undefined Bond Stereocenter Count | 0 |
| 所有立体化学键的总数The total count of all stereochemical bonds | 0 |
| 共价键合单元计数Covalently-Bonded Unit Count | 1 |
| Purity(HPLC) | 98-100(%) |
|---|---|
| Proton NMR spectrum | Conforms to Structure |
通过匹配包装上的批号来查找并下载产品的 COA,每批产品都进行了严格的验证,您可放心使用!
| 批号(Lot Number) | 证书类型 | 日期 | 货号 |
|---|---|---|---|
| 分析证书 | 23-05-10 | G414233 | |
| 分析证书 | 23-05-10 | G414233 | |
| 分析证书 | 23-05-10 | G414233 | |
| 分析证书 | 23-05-10 | G414233 | |
| 分析证书 | 23-05-10 | G414233 | |
| 分析证书 | 23-05-10 | G414233 | |
| 分析证书 | 23-05-10 | G414233 | |
| 分析证书 | 23-05-10 | G414233 | |
| 分析证书 | 23-05-10 | G414233 | |
| 分析证书 | 23-05-10 | G414233 | |
| 分析证书 | 23-05-10 | G414233 |
| 1. Tanaka Y, Chen ZJ. (2012) STING specifies IRF3 phosphorylation by TBK1 in the cytosolic DNA signaling pathway.. Sci Signal, 5 (214): (ra20). [PMID:22394562] |
| 2. Zhan Z, Cao H, Xie X, Yang L, Zhang P, Chen Y, Fan H, Liu Z, Liu X. (2015) Phosphatase PP4 Negatively Regulates Type I IFN Production and Antiviral Innate Immunity by Dephosphorylating and Deactivating TBK1.. J Immunol, 195 (8): (3849-57). [PMID:26363053] |
| 3. Thomson DW, Poeckel D, Zinn N, Rau C, Strohmer K, Wagner AJ, Graves AP, Perrin J, Bantscheff M, Duempelfeld B et al.. (2019) Discovery of GSK8612, a Highly Selective and Potent TBK1 Inhibitor.. ACS Med Chem Lett, 10 (5): (780-785). [PMID:31097999] [10.1021/acsmedchemlett.9b00027] |